Cargando…

Diagnostic and therapeutic potential of RNASET2 in Crohn’s disease: Disease-risk polymorphism modulates allelic-imbalance in expression and circulating protein levels and recombinant-RNASET2 attenuates pro-inflammatory cytokine secretion

Ribonuclease T2 gene (RNASET2) variants are associated in genome wide association studies (GWAS) with risk for several autoimmune diseases, including Crohn’s disease (CD). In T cells, a functional and biological relationship exists between TNFSF15-mediated enhancement of IFN−γ production, mucosal in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biener-Ramanujan, Eva, Rosier, Florian, Coetzee, Simon G., McGovern, Dermot D. P., Hazelett, Dennis, Targan, Stephan R., Gonsky, Rivkah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709281/ https://www.ncbi.nlm.nih.gov/pubmed/36466822 http://dx.doi.org/10.3389/fimmu.2022.999155

Ejemplares similares

Human recombinant RNASET2: A potential anti-cancer drug
por: Roiz, Levava, et al.
Publicado: (2016)

Mammalian mitochondrial RNAs are degraded in the mitochondrial intermembrane space by RNASET2
por: Liu, Peipei, et al.
Publicado: (2017)

RNaseT2 knockout rats exhibit hippocampal neuropathology and deficits in memory
por: Sinkevicius, Kerstin W., et al.
Publicado: (2018)

Chromosome 6 encoded RNaseT2 protein is a cell growth regulator
por: Liu, Jinglan, et al.
Publicado: (2010)

Molecular characterization and immune modulation properties of Clonorchis sinensis-derived RNASET2
por: Xu, Yanquan, et al.
Publicado: (2013)

Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene
por: Acquati, Francesco, et al.
Publicado: (2019)

Expression, Location, Clinical Implication, and Bioinformatics Analysis of RNASET2 in Gastric Adenocarcinoma
por: Zeng, Zhi, et al.
Publicado: (2020)

Regulation of mitochondrion-associated cytosolic ribosomes by mammalian mitochondrial ribonuclease T2 (RNASET2)
por: Huang, Jinliang, et al.
Publicado: (2018)

Zebrafish disease model of human RNASET2-deficient cystic leukoencephalopathy displays abnormalities in early microglia
por: Weber, Thomas, et al.
Publicado: (2020)

HTLV-1 Tax directly modulates expression of the CDK6 and RNASET2 genes
por: Polakowski, Nicholas, et al.
Publicado: (2011)

FBXO6-mediated RNASET2 ubiquitination and degradation governs the development of ovarian cancer
por: Ji, Mei, et al.
Publicado: (2021)

3D Reconstruction of HvRNASET2 Molecule to Understand Its Antibacterial Role
por: Baranzini, Nicolò, et al.
Publicado: (2020)

Interferon-driven brain phenotype in a mouse model of RNaseT2 deficient leukoencephalopathy
por: Kettwig, Matthias, et al.
Publicado: (2021)

RNASET2 tag SNP but not CCR6 polymorphisms is associated with autoimmune thyroid diseases in the Chinese Han population
por: Chen, Xiao-jun, et al.
Publicado: (2015)

Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cells
por: Acquati, Francesco, et al.
Publicado: (2011)

Pleiotropic modes of action in tumor cells of RNASET2, an evolutionary highly conserved extracellular RNase
por: Lualdi, Marta, et al.
Publicado: (2015)

The failure of microglia to digest developmental apoptotic cells contributes to the pathology of RNASET2‐deficient leukoencephalopathy
por: Hamilton, Noémie, et al.
Publicado: (2020)

Stress-induced RNASET2 overexpression mediates melanocyte apoptosis via the TRAF2 pathway in vitro
por: Wang, Q, et al.
Publicado: (2014)

Human RNASET2 derivatives as potential anti-angiogenic agents: actin binding sequence identification and characterization
por: Nesiel-Nuttman, Liron, et al.
Publicado: (2014)

Human recombinant truncated RNASET2, devoid of RNase activity; A potential cancer therapeutic agent
por: Nesiel-Nuttman, Liron, et al.
Publicado: (2014)

A Cell-Autonomous Oncosuppressive Role of Human RNASET2 Affecting ECM-Mediated Oncogenic Signaling
por: Roggiani, Francesca, et al.
Publicado: (2019)

Antimicrobial Role of RNASET2 Protein During Innate Immune Response in the Medicinal Leech Hirudo verbana
por: Baranzini, Nicolò, et al.
Publicado: (2020)

HvRNASET2 Regulate Connective Tissue and Collagen I Remodeling During Wound Healing Process
por: Baranzini, Nicolò, et al.
Publicado: (2021)

Systematic analysis of RNASET2 gene as a potential prognostic and immunological biomarker in clear cell renal cell carcinoma
por: Liu, Yifu, et al.
Publicado: (2023)

Hypoxia Enhances the Expression of RNASET2 in Human Monocyte-Derived Dendritic Cells: Role of PI3K/AKT Pathway
por: Monaci, Sara, et al.
Publicado: (2021)

Human RNASET2: A Highly Pleiotropic and Evolutionary Conserved Tumor Suppressor Gene Involved in the Control of Ovarian Cancer Pathogenesis
por: Bruno, Antonino, et al.
Publicado: (2022)

HIF2α‐induced upregulation of RNASET2 promotes triglyceride synthesis and enhances cell migration in clear cell renal cell carcinoma
por: Quan, Yanmei, et al.
Publicado: (2023)

RNASET2-deficient leukoencephalopathy mimicking congenital CMV infection and Aicardi-Goutieres syndrome: a case report with a novel pathogenic variant
por: Kameli, Reyhaneh, et al.
Publicado: (2019)

A Pre- and Co-Knockdown of RNAseT Enzyme, Eri-1, Enhances the Efficiency of RNAi Induced Gene Silencing in Caenorhabditis elegans
por: Jadiya, Pooja, et al.
Publicado: (2014)

Performance Characteristics of a Clinical Decision Support Tool for Disease Complications in Crohn’s Disease
por: Siegel, Corey A, et al.
Publicado: (2021)

Overexpression of Murine Rnaset2 in a Colon Syngeneic Mouse Carcinoma Model Leads to Rebalance of Intra-Tumor M1/M2 Macrophage Ratio, Activation of T Cells, Delayed Tumor Growth, and Rejection
por: De Vito, Annarosaria, et al.
Publicado: (2020)

Reduced expression of COVID-19 host receptor, ACE2 is associated with small bowel inflammation, more severe disease, and response to anti-TNF therapy in Crohn’s disease
por: Potdar, Alka A., et al.
Publicado: (2020)

Redox imbalance in Crohn's disease patients is modulated by Azathioprine
por: Tavassolifar, Mohammad Javad, et al.
Publicado: (2021)

Reprograming of gut microbiome energy metabolism by the FUT2 Crohn's disease risk polymorphism
por: Tong, Maomeng, et al.
Publicado: (2014)

Crohn’s disease in endoscopic remission, obesity, and cases of high genetic risk demonstrates overlapping shifts in the colonic mucosal-luminal interface microbiome
por: Jacobs, Jonathan P., et al.
Publicado: (2022)

Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study
por: Wallis, Dinny, et al.
Publicado: (2013)

Mitochondrial complex I modulation targets metabolic plasticity in breast cancer cells
por: Ramanujan, V Krishnan, et al.
Publicado: (2014)

Delimiting Allelic Imbalance of TYMS by Allele-Specific Analysis
por: Balboa-Beltrán, Emilia, et al.
Publicado: (2015)

Imbalance of Controlled Death in Peripheral Blood Lymphocytes in Crohn’s Disease and Ulcerative Colitis
por: Dudzińska, Ewa, et al.
Publicado: (2019)

Novel Microbial-Based Immunotherapy Approach for Crohn's Disease
por: Sutcliffe, Simon, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hdehebemd5uuapomha9cn906bm